We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

ANGLE

Revenue building and growth opportunities are developing

Lighthouse | 07 September 2023

Scancell

Upcoming SCIB1 data could provide first proof of concept

Update | 05 September 2023

HUTCHMED

Delivering on sharpened goals and priorities

Lighthouse | 01 August 2023

Arecor Therapeutics

Pipeline and partnership progress plus upcoming catalysts

Lighthouse | 20 July 2023

Futura Medical

Haleon to commercialise MED3000 in the US

Lighthouse | 17 July 2023

Futura Medical

Key takeaways from Investor Seminar

Lighthouse | 26 June 2023

HUTCHMED

ASCO 2023: a growing body of evidence for fruquintinib

Update | 22 June 2023

Futura Medical

First months of Eroxon launch suggest a successful start

Lighthouse | 22 June 2023

Futura Medical

MED3000 FDA clearance marks a major step in the US

Lighthouse | 12 June 2023

Avacta

Diagnostics build-out continues with Coris acquisition

Lighthouse | 01 June 2023
1 2 3 4 5 6 7 8 9 10 >
405 results found.